Suven Pharmaceuticals is a listed CDMO while Cohance Lifesciences is an unlisted company which was formed to create a new brand entity for three formerly Advent-acquired companies
Suven Pharmaceuticals is a listed CDMO and Cohance Lifesciences is an unlisted API and CDMO platform. Both are part of private equity firm Advent International s India portfolio.
Aadhar Housing Finance IPO comprises a fresh equity issue of Rs 1,000 crore and an offer for sale of Rs 4000 crore. Under the OFS, promoter BCP Topco VII Pte will offload its stake. BCP Topco, which is the promoter, and an affiliate of funds managed by Blackstone, currently holds 98.7% of the pre-offer issued, subscribed, and paid-up equity share capital.